Compare HROW & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | MLKN |
|---|---|---|
| Founded | 1998 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2008 | 1994 |
| Metric | HROW | MLKN |
|---|---|---|
| Price | $30.61 | $20.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $65.00 | N/A |
| AVG Volume (30 Days) | 486.5K | ★ 585.8K |
| Earning Date | 11-09-2026 | 09-22-2026 |
| Dividend Yield | N/A | ★ 3.81% |
| EPS Growth | 71.43 | ★ 344.44 |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $3,841,700,000.00 |
| Revenue This Year | $28.81 | $2.23 |
| Revenue Next Year | $53.97 | $4.25 |
| P/E Ratio | ★ N/A | $15.24 |
| Revenue Growth | N/A | ★ 4.68 |
| 52 Week Low | $28.54 | $13.77 |
| 52 Week High | $54.98 | $24.71 |
| Indicator | HROW | MLKN |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 29.85 |
| Support Level | $28.54 | $19.12 |
| Resistance Level | $35.43 | $19.57 |
| Average True Range (ATR) | 1.25 | 0.79 |
| MACD | -0.21 | -0.10 |
| Stochastic Oscillator | 11.48 | 0.00 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.